Cadrenal Therapeutics, Inc. (CVKD)
1.03
+0.03
(+3.00%)
USD |
NASDAQ |
Nov 06, 10:16
Cadrenal Therapeutics Total Liabilities (Quarterly) : 1.497M for June 30, 2026
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.497M |
| March 31, 2026 | 1.065M |
| December 31, 2025 | 1.588M |
| September 30, 2025 | 1.353M |
| June 30, 2025 | 1.680M |
| March 31, 2025 | 1.840M |
| December 31, 2024 | 2.684M |
| September 30, 2024 | 1.267M |
| June 30, 2024 | 1.465M |
| Date | Value |
|---|---|
| March 31, 2024 | 0.8563M |
| December 31, 2023 | 0.8269M |
| September 30, 2023 | 0.5658M |
| June 30, 2023 | 0.3831M |
| March 31, 2023 | 0.4168M |
| December 31, 2022 | 6.329M |
| September 30, 2022 | 1.725M |
| June 30, 2022 | 0.9142M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 896.90M |
| Corcept Therapeutics, Inc. | 200.29M |
| Veru, Inc. | 8.651M |
| Johnson & Johnson | 115.90B |
| Eli Lilly & Co. | 107.80B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.589M |
| Shareholders Equity (Quarterly) | 4.092M |
| Current Ratio | 3.666 |